Syndrome Metabolic Markers, Fitness and Body Fat Is Associated with Sleep Quality in Women with Severe/Morbid Obesity.
exercise
morbid obesity
quality of life
sleep quality
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
03 09 2021
03 09 2021
Historique:
received:
19
08
2021
revised:
26
08
2021
accepted:
30
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Sleep is an important modulator of neuroendocrine function and glucose metabolism. Poor sleep quality is related to metabolic and endocrine alterations, including decreased glucose tolerance, decreased insulin sensitivity, and increased hunger and appetite. The aim of the present study was to determine the association between sleep quality with metabolic syndrome (MetS) markers, fitness and body fat of women with severe/morbid obesity. This cross-sectional study included 26 women with severe/morbid obesity. Fasting plasma glucose (FPG), high-density lipids (HDL-c), triglycerides (TGs), and the metabolic outcomes total cholesterol (Tc) and low-density lipids (LDL-c), systolic (SBP) and diastolic blood pressure (DBP), body composition and fitness were measured. Poor sleep quality showed a positive association with body fat (%) ≥ 48.2 (OR; 8.39, 95% CI; 1.13-62.14, sleep quality is associated with health markers in women with severe/morbid obesity.
Sections du résumé
BACKGROUND
Sleep is an important modulator of neuroendocrine function and glucose metabolism. Poor sleep quality is related to metabolic and endocrine alterations, including decreased glucose tolerance, decreased insulin sensitivity, and increased hunger and appetite.
OBJECTIVE
The aim of the present study was to determine the association between sleep quality with metabolic syndrome (MetS) markers, fitness and body fat of women with severe/morbid obesity.
METHODS
This cross-sectional study included 26 women with severe/morbid obesity. Fasting plasma glucose (FPG), high-density lipids (HDL-c), triglycerides (TGs), and the metabolic outcomes total cholesterol (Tc) and low-density lipids (LDL-c), systolic (SBP) and diastolic blood pressure (DBP), body composition and fitness were measured.
RESULTS
Poor sleep quality showed a positive association with body fat (%) ≥ 48.2 (OR; 8.39, 95% CI; 1.13-62.14,
CONCLUSION
sleep quality is associated with health markers in women with severe/morbid obesity.
Identifiants
pubmed: 34501884
pii: ijerph18179294
doi: 10.3390/ijerph18179294
pmc: PMC8431712
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
Obes Rev. 2017 Feb;18 Suppl 1:15-24
pubmed: 28164449
Med Sci Sports Exerc. 2015 May;47(5):960-6
pubmed: 25207930
Ann N Y Acad Sci. 2008;1129:287-304
pubmed: 18591489
Sleep Breath. 2019 Jun;23(2):679-685
pubmed: 30402777
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Sleep Med Rev. 2010 Jun;14(3):191-203
pubmed: 19932976
Sleep. 2016 Aug 19;39(9):1629-1630
pubmed: 27568809
Int J Environ Res Public Health. 2019 Nov 06;16(22):
pubmed: 31698817
Sleep. 2013 Dec 01;36(12):1859-65
pubmed: 24293760
Sleep Med. 2015 Oct;16(10):1225-8
pubmed: 26429750
Medicina (Kaunas). 2018 Nov 19;54(5):
pubmed: 30463242
Climacteric. 2017 Feb;20(1):72-79
pubmed: 28042731
J Sleep Res. 2017 Aug;26(4):453-460
pubmed: 28220551
Arch Intern Med. 2006 Sep 18;166(16):1768-74
pubmed: 16983057
Multidiscip Respir Med. 2016 Jul 12;11:28
pubmed: 27408717
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Am J Hum Biol. 2010 Jul-Aug;22(4):473-5
pubmed: 20039256
Metab Syndr Relat Disord. 2018 May;16(4):183-189
pubmed: 29649378
Int J Environ Res Public Health. 2021 Apr 09;18(8):
pubmed: 33918629
Best Pract Res Clin Endocrinol Metab. 2010 Oct;24(5):687-702
pubmed: 21112019
Acta Diabetol. 2008 Dec;45(4):225-9
pubmed: 18685806
Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):402-12
pubmed: 21659802
Can J Cardiol. 2015 Jul;31(7):873-9
pubmed: 26037823
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:74-88
pubmed: 25662277
Sleep Med. 2016 Feb;18:19-35
pubmed: 26431758
Obesity (Silver Spring). 2016 Feb;24(2):335-41
pubmed: 26704169
Respir Res. 2020 Jan 29;21(1):35
pubmed: 31996224
Psychoneuroendocrinology. 2018 Dec;98:46-51
pubmed: 30098512
Obes Surg. 2012 Jun;22(6):890-5
pubmed: 22101850
J Nutr Metab. 2017;2017:7307618
pubmed: 28421144
Hypertension. 2003 Dec;42(6):1206-52
pubmed: 14656957
Blood Press. 2014 Feb;23(1):3-16
pubmed: 24359485
Fam Pract. 2012 Feb;29(1):30-5
pubmed: 21795758
Chest. 2008 Sep;134(3):539-545
pubmed: 18779193
Int J Environ Res Public Health. 2018 Oct 18;15(10):
pubmed: 30340366
Diabetes Care. 2019 Jul;42(7):1326-1332
pubmed: 31048411
J Sports Med Phys Fitness. 2007 Dec;47(4):462-7
pubmed: 18091688
Metabolism. 2018 Jul;84:56-66
pubmed: 29510179
Mediators Inflamm. 2015;2015:493409
pubmed: 25944984
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):962-973
pubmed: 31125517
Crit Rev Food Sci Nutr. 2019;59(13):2158-2165
pubmed: 30335476